Dudediligence.

Climb Bio, Inc

CLYMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$8.9MSep ’24−$8.4MDec ’24−$20.8MMar ’25−$8.7MJun ’25−$12.9MSep ’25−$17.5MDec ’25−$13.7MMar ’26−$13.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$35.7M−$45.1M−$40.3M−$82.0M−$67.9M
Net income−$47.5M−$45.2M−$35.1M−$73.9M−$59.9M
Operating cash flow−$36.1M−$37.4M−$20.6M−$15.6M−$54.4M
Free cash flownone on filenone on file−$20.6M−$15.6M−$54.5M
Cash$46.9M$43.6M$93.1M$87.2M$35.7M
Shares outstanding26.6M26.6M27.7M67.3M47.8M